TRIAZOLAM

Triazolam Adverse Events Reported to the FDA Over Time

How are Triazolam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Triazolam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Triazolam is flagged as the suspect drug causing the adverse event.

Most Common Triazolam Adverse Events Reported to the FDA

What are the most common Triazolam adverse events reported to the FDA?

Drug Ineffective	63 (6.67%)
Somnolence	17 (1.8%)
Suicide Attempt	17 (1.8%)
Overdose	15 (1.59%)
Depression	11 (1.16%)
Insomnia	11 (1.16%)
Intentional Overdose	11 (1.16%)
Multiple Drug Overdose	11 (1.16%)
Drug Interaction	10 (1.06%)
Drug Toxicity	10 (1.06%)
Electrocardiogram Qt Prolonged	10 (1.06%)
	Show More
Sopor	10 (1.06%)
Completed Suicide	9 (.95%)
Blepharospasm	8 (.85%)
Rhabdomyolysis	8 (.85%)
Condition Aggravated	7 (.74%)
Death	7 (.74%)
Heart Rate Decreased	7 (.74%)
Incorrect Dose Administered	7 (.74%)
Suicidal Ideation	7 (.74%)
Altered State Of Consciousness	6 (.63%)
Asthenia	6 (.63%)
Depressed Level Of Consciousness	6 (.63%)
Dizziness	6 (.63%)
Dyspnoea	6 (.63%)
Headache	6 (.63%)
Loss Of Consciousness	6 (.63%)
Nausea	6 (.63%)
Pain	6 (.63%)
Rash	6 (.63%)
Syncope	6 (.63%)
Torsade De Pointes	6 (.63%)
Vomiting	6 (.63%)
White Blood Cell Count Increased	6 (.63%)
Anxiety	5 (.53%)
Blood Lactate Dehydrogenase Increas...	5 (.53%)
Blood Pressure Increased	5 (.53%)
Decreased Appetite	5 (.53%)
Fatigue	5 (.53%)
Head Injury	5 (.53%)
Abdominal Discomfort	4 (.42%)
Abnormal Behaviour	4 (.42%)
Agitation	4 (.42%)
Aspiration	4 (.42%)
Coeliac Disease	4 (.42%)
Dehydration	4 (.42%)
Delirium	4 (.42%)
Disturbance In Attention	4 (.42%)
Drug Dependence	4 (.42%)
Drug Exposure During Pregnancy	4 (.42%)
Drug Screen Negative	4 (.42%)
Erythema	4 (.42%)
Fall	4 (.42%)
Feeling Abnormal	4 (.42%)
Hallucination	4 (.42%)
Heart Rate Increased	4 (.42%)
Hypertension	4 (.42%)
Hypotension	4 (.42%)
Inflammation	4 (.42%)
Malaise	4 (.42%)
Oedema	4 (.42%)
Product Quality Issue	4 (.42%)
Pruritus	4 (.42%)
Sedation	4 (.42%)
Sinus Bradycardia	4 (.42%)
Stevens-johnson Syndrome	4 (.42%)
Thyroidectomy	4 (.42%)
Ventricular Tachycardia	4 (.42%)
Abortion Spontaneous	3 (.32%)
Amnesia	3 (.32%)
Arthritis	3 (.32%)
Blood Creatine Phosphokinase Increa...	3 (.32%)
Blood Pressure Decreased	3 (.32%)
Blood Urea Increased	3 (.32%)
Bradycardia	3 (.32%)
Bradyphrenia	3 (.32%)
C-reactive Protein Increased	3 (.32%)
Caesarean Section	3 (.32%)
Cardiac Failure Congestive	3 (.32%)
Constipation	3 (.32%)
Depressed Mood	3 (.32%)
Diabetes Mellitus	3 (.32%)
Discomfort	3 (.32%)
Drug Effect Decreased	3 (.32%)
Drug Withdrawal Syndrome	3 (.32%)
Dyskinesia	3 (.32%)
Faecal Incontinence	3 (.32%)
Hyperventilation	3 (.32%)
Hypokinesia	3 (.32%)
Impaired Driving Ability	3 (.32%)
Irritability	3 (.32%)
Memory Impairment	3 (.32%)
Multiple Drug Overdose Intentional	3 (.32%)
Po2 Decreased	3 (.32%)
Poor Quality Sleep	3 (.32%)
Pyrexia	3 (.32%)
Renal Failure	3 (.32%)
Renal Impairment	3 (.32%)
Shock	3 (.32%)
Sleep Disorder	3 (.32%)
Treatment Noncompliance	3 (.32%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Triazolam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triazolam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Triazolam

What are the most common Triazolam adverse events reported to the FDA?

Therapeutic And Nontherapeutic Effe...	91 (9.63%)
Neurological	78 (8.25%)
Medication Errors	51 (5.4%)
Suicidal And Self-injurious Behavio...	36 (3.81%)
Cardiac And Vascular Investigations	33 (3.49%)
Sleep Disorders	29 (3.07%)
Respiratory	27 (2.86%)
Epidermal And Dermal Conditions	24 (2.54%)
Cardiac Arrhythmias	22 (2.33%)
Gastrointestinal Signs	20 (2.12%)
Chemical Injury And Poisoning	17 (1.8%)
	Show More
Depressed Mood Disorders	17 (1.8%)
Injuries	15 (1.59%)
Movement Disorders	14 (1.48%)
Muscle	13 (1.38%)
Lifestyle Issues	12 (1.27%)
Mental Impairment	12 (1.27%)
Anxiety Disorders	11 (1.16%)
Enzyme	11 (1.16%)
Ocular Neuromuscular	11 (1.16%)
Psychiatric	11 (1.16%)
Decreased And Nonspecific Blood Pre...	10 (1.06%)
Hematology Investigations	10 (1.06%)
Fatal Outcomes	9 (.95%)
Infections - Pathogen Unspecified	9 (.95%)
Toxicology And Therapeutic Drug Mon...	9 (.95%)
Disturbances In Thinking	8 (.85%)
Renal Disorders	8 (.85%)
Appetite And General Nutritional	7 (.74%)
Deliria	7 (.74%)
Electrolyte And Fluid Balance Condi...	7 (.74%)
Hepatic And Hepatobiliary	7 (.74%)
Lower Respiratory Tract Disorders	7 (.74%)
Oral Soft Tissue Conditions	7 (.74%)
Headaches	6 (.63%)
Hepatobiliary	6 (.63%)
Endocrine Gland Therapeutic Procedu...	5 (.53%)
Glucose Metabolism Disorders	5 (.53%)
Gastrointestinal Motility And Defec...	4 (.42%)
Gastrointestinal Ulceration And Per...	4 (.42%)
Joint	4 (.42%)
Malabsorption Conditions	4 (.42%)
Metabolic, Nutritional And Blood Ga...	4 (.42%)
Neurological, Special Senses And Ps...	4 (.42%)
Obstetric And Gynecological Therape...	4 (.42%)
Personality Disorders	4 (.42%)
Physical Examination Topics	4 (.42%)
Pregnancy, Labour, Delivery And Pos...	4 (.42%)
Product Quality Issues	4 (.42%)
Protein And Chemistry Analyses	4 (.42%)
Psychiatric And Behavioural Symptom...	4 (.42%)
Renal And Urinary Tract Investigati...	4 (.42%)
Seizures	4 (.42%)
Tongue Conditions	4 (.42%)
Vascular Hypertensive	4 (.42%)
Abortions And Stillbirth	3 (.32%)
Anemias Nonhemolytic And Marrow Dep...	3 (.32%)
Bacterial Infectious	3 (.32%)
Body Temperature Conditions	3 (.32%)
Bone And Joint Injuries	3 (.32%)
Bronchial Disorders	3 (.32%)
Central Nervous System Vascular	3 (.32%)
Communication Disorders	3 (.32%)
Heart Failures	3 (.32%)
Hematological And Lymphoid Tissue T...	3 (.32%)
Legal Issues	3 (.32%)
Manic And Bipolar Mood Disorders	3 (.32%)
Mood Disorders	3 (.32%)
Neuromuscular	3 (.32%)
Ocular Infections, Irritations And ...	3 (.32%)
Peripheral Neuropathies	3 (.32%)
Skin Vascular Abnormalities	3 (.32%)
Sleep Disturbances	3 (.32%)
Allergic Conditions	2 (.21%)
Bone And Joint Therapeutic Procedur...	2 (.21%)
Bone Disorders	2 (.21%)
Coagulopathies And Bleeding Diathes...	2 (.21%)
Embolism And Thrombosis	2 (.21%)
Endocrine Neoplasms Malignant And U...	2 (.21%)
Exocrine Pancreas Conditions	2 (.21%)
Fungal Infectious	2 (.21%)
Gallbladder	2 (.21%)
Gastrointestinal Hemorrhages	2 (.21%)
Gastrointestinal Tract Disorders Co...	2 (.21%)
Impulse Control	2 (.21%)
Inner Ear And Viiith Cranial Nerve	2 (.21%)
Lipid Metabolism	2 (.21%)
Musculoskeletal And Connective Tiss...	2 (.21%)
Neonatal And Perinatal Conditions	2 (.21%)
Ocular Sensory Symptoms	2 (.21%)
Pericardial	2 (.21%)
Peritoneal And Retroperitoneal Cond...	2 (.21%)
Reproductive Neoplasms Female Benig...	2 (.21%)
Therapeutic Procedures And Supporti...	2 (.21%)
Vascular Inflammations	2 (.21%)
Vulvovaginal Disorders	2 (.21%)
Water, Electrolyte And Mineral	2 (.21%)
Angiedema And Urticaria	1 (.11%)
Cardiac Disorder Signs	1 (.11%)
Central Nervous System Infections A...	1 (.11%)
Changes In Physical Activity	1 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Triazolam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triazolam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.